Genitourinary Cancer Clinical Trials

8 recruiting

Genitourinary Cancer Trials at a Glance

10 actively recruiting trials for genitourinary cancer are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 1 with 2 trials, with the heaviest enrollment activity in Bethesda, Toronto, and Alcázar de San Juan. Lead sponsors running genitourinary cancer studies include National Cancer Institute (NCI), British Columbia Cancer Agency, and Algemeen Ziekenhuis Maria Middelares.

Browse genitourinary cancer trials by phase

Treatments under study

About Genitourinary Cancer Clinical Trials

Looking for clinical trials for Genitourinary Cancer? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Genitourinary Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Genitourinary Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 1

Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies

Urothelial CancerBladder CancerGenitourinary Cancer+2 more
National Cancer Institute (NCI)100 enrolled1 locationNCT04235777
Recruiting

Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

Breast CancerLung CancerMelanoma+7 more
University Health Network, Toronto7,000 enrolled1 locationNCT07524114
Recruiting

Rapid Autopsy and Procurement of Cancer Tissue

Lung CancersMesotheliomaThymus Tumors+2 more
National Cancer Institute (NCI)275 enrolled1 locationNCT01851395
Recruiting

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Breast CancerEsophageal CancerProstate Cancer+10 more
Washington University School of Medicine100 enrolled1 locationNCT04354064
Recruiting
Phase 1

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Breast CancerColorectal, CancerOvarian Cancer+4 more
National Cancer Institute (NCI)210 enrolled1 locationNCT06253520
Recruiting

Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.

Genitourinary Cancers
Spanish Oncology Genito-Urinary Group500 enrolled84 locationsNCT06724159
Recruiting

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

Urothelial CancerBladder CancerGenitourinary Cancer+2 more
National Cancer Institute (NCI)1,100 enrolled1 locationNCT04923178
Recruiting

Discharge Medication Use Post-Operatively in GU Cancer Patients

Genitourinary Cancer
Wake Forest University Health Sciences684 enrolled1 locationNCT06795087
Recruiting
Phase 2

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Breast CancerSarcomaLung Cancer+6 more
British Columbia Cancer Agency200 enrolled2 locationsNCT04273061
Recruiting
Not Applicable

High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

Breast CarcinomaHead and Neck CancerThyroid Cancer+10 more
Algemeen Ziekenhuis Maria Middelares150 enrolled1 locationNCT06835426